'Biomarkers in Clinical Trials'
In this session, we will explore the vital importance of biomarkers in clinical trials, highlighting their role in monitoring glomerular disease progression, treatment response, and patient outcomes. Experts will cover recent advances in…

Happening now 👇

👀 tomorrow 5/5/24 at 8am (PT)/ 10am (CT)/ 11am (ET)👇

A próxima sessão da GlomCon Portugal é a 31 de Maio! Não perca esta oportunidade de aprendizagem e partilha de experiência!
GlomCon

🔥 Hey guys, you absolutely need to check out this amazing website if you haven't already! 🕵️‍♀️🔰
🗝️Head over to 👉enrollmypatient.org and 👉glomcon.org GlomCon
⚡This is a curated list of available trials for pts and Drs, accompanied by educational information…

Glomerular Diseases in Transplantation GlomCon Fellowship Podocin today - a tour de force w Basu Gopal + Matt Bottomley Andreas Kousios & Wai Lim leading case discussions

Beautiful visual summary of recurrent and de novo GN Post #Kidney Transplant 🤩
GlomCon 👏

“Exploring Endpoints in Glomerular Disease Trials' 💊 - Join us for a session focusing on current approaches and controversies in defining clinical trial endpoints for glomerular diseases, shedding light on the evolving research landscape in this field.

Register here 👉…

Such a great infographic by Dr Priti MD,FASN🇮🇳 (प्रिति)
on therapies in pipeline for FSGS
GlomCon

enrollmypatient.org

“Onconefrología Pediátrica”

Por: Dr. Miguel Liern 👨🏻‍⚕️🇦🇷

Total de participantes: 179
Transmitido en: 16 países

Si te perdiste la sesión, o deseas verla de nuevo, entra a:
my.glomcon.org

#GlomConILA #GlomConAmor #MeGusta

A special day at GlomCon today with Basu Gopal expounding the complexities of recurrent GN post🫘Tx. Lots of concepts, data, takeaways & great slides!

Well done with the illustrative case on rec FSGS nyiminhan 👍🏻

Quoting Kate Robson
‘A tour de force on current evidence’🎖️

A detailed list of all the current Lupus Nephritis trials at a glance! Fabulous work by Anjana Gopal. GlomCon
enrollmypatient.org/lupus

American Kidney Fund AMPLITUDE Trial. A Phase 2/3 adaptive study for adult and pediatric participants with APOL1- Mediated Kidney Disease.

Key Inclusion Criteria:
APOL1 genotype of G1/G1, G2/G2, or G1/G2 and Proteinuria. No biopsy required.

Learn more here 👇
enrollmypatient.org/inaxaplin…

Just a while back, I crossed paths with this incredible lady battling IgAN and advanced CKD. From being a top pediatrician to a patient advocate, she's killing it! Loma Linda U. Health ❤️

Shoutout to National Kidney Foundation Silvi Shah, MD, MS for having us on board. Brittany's journey is truly inspiring! 🌟…

Did you know that those of us with ancestors from west or central Africa & a certain variation of the APOL1 genes have an increased risk of developing APOL1-mediated kidney disease (AMKD)? Become #APOL1Aware & join the American Kidney Fund in AKMD Awareness Day: kidneyfund.org/APOL1aware

Join GlomCon in its Kidney Transplantation Series this Sunday:

Updates in Transplant Onconephrology by Dr. Naoka Murakami and Dr. Germaine Wong

ID: 875 5077 1266
Passcode 202122

sign up 👉🏻 bit.ly/signup-glomcon

#GlomCon

参加 GlomCon China 的首届会议：
北京时间5 月 5 日上午 10 点（GMT+8）

题目: Alport 综合征疾病进展预测指标的探索与评价

讲者: 林芙君, 上海交通大学医学院附属新华医院肾脏科

主持人: 刘松, 助理教授, 新墨西哥大学附属医院

#腾讯会议 ：577-409-841
会议密码：123456

#GlomConChina

Starting now 👇